Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...
AI-generated digital twins to strengthen SOLA's early-phase ALS study and support disciplined, data-driven development decisions SAN FRANCISCO, CA / ACCESS Newswire / March 10, 2026 / Unlearn, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results